Carcinoma of unknown primary origin with isolated adrenal metastasis: a report of two cases.
暂无分享,去创建一个
H. Sasano | H. Ikeda | K. Ohtsubo | S. Mori | T. Yoneda | Yuto Yamazaki | M. Kometani | Y. Takeda | Yuji Maeda | D. Aono | S. Karashima | Mikiya Usukura
[1] B. Stuck,et al. Clinical relevance of CYFRA 21-1 as a tumour marker in patients with oropharyngeal squamous cell carcinoma , 2020, European Archives of Oto-Rhino-Laryngology.
[2] W. Young,et al. Comparison between functional and non-functional adrenocortical carcinoma. , 2019, Surgery.
[3] Eric Baudin,et al. European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. , 2018, European journal of endocrinology.
[4] C. Blanpain,et al. Deciphering the cells of origin of squamous cell carcinomas , 2018, Nature Reviews Cancer.
[5] S. Kurosaka,et al. Laparoscopic adrenalectomy for metastatic adrenal tumor , 2014, Asian journal of endoscopic surgery.
[6] C. Wood,et al. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. , 2013, European journal of endocrinology.
[7] C. Lohse,et al. Adrenalectomy Improves Outcomes of Selected Patients with Metastatic Carcinoma , 2012, World Journal of Surgery.
[8] J. Thigpen. Combination Chemotherapy in Advanced Adrenocortical Carcinoma , 2012 .
[9] F. Beuschlein,et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. , 2010, The Journal of clinical endocrinology and metabolism.
[10] G. Hammer,et al. Management of adrenocortical carcinoma. , 2009, The Journal of the National Comprehensive Cancer Network.
[11] J. Monchik,et al. Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience. , 2009, Archives of surgery.
[12] Martin Fassnacht,et al. Clinical management of adrenocortical carcinoma. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[13] D. Schteingart. Adrenocortical Carcinoma in the United States: Treatment Utilization and Prognostic Factors , 2009 .
[14] Martin Fassnacht,et al. Adrenocortical Carcinoma: Clinical Update , 2006 .
[15] Linda Ng,et al. Adrenocortical carcinoma: diagnosis, evaluation and treatment. , 2003, The Journal of urology.
[16] K. Lam,et al. Metastatic tumours of the adrenal glands: a 30‐year experience in a teaching hospital , 2002, Clinical endocrinology.
[17] D. Rades,et al. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Y. Chapuis,et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group , 2001, World Journal of Surgery.
[19] J. Abbruzzese,et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. , 1998, Surgery.
[20] P. Puech,et al. Adrenalectomy for a solitary adrenal metastasis from lung cancer. , 1998, The Annals of thoracic surgery.
[21] R. Bellantone,et al. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. , 1996, Surgery.
[22] H. Sasano,et al. Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. , 1995, Human pathology.
[23] J. Daurès,et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. , 1993, Cancer research.
[24] P Blondeau,et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. , 1990, The New England journal of medicine.